Indian Vaccine Exports May Halt If Central Authority Does Not Comply With GMP Norms
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Large vaccine manufacturers in India may not be able to export their key products for long, nor can they cater to domestic demand, as the apex testing laboratory for vaccines - the Central Research Institute - has been de-recognized from doing such tests by the Drug Controller General of India.